Dedhar S, Gray V
Department of Advanced Therapeutics, Cancer Control Agency of British Columbia, Vancouver, Canada.
J Cell Biol. 1990 Jun;110(6):2185-93. doi: 10.1083/jcb.110.6.2185.
We report the isolation from two human neuroblastoma cell lines of an Arg-Gly-Asp-dependent integrin complex capable of binding to vitronectin, fibronectin, and type I collagen. The two neuroblastoma cell lines, SK-N-SH and IMR-32, exhibit specific attachment to fibronectin and type I collagen. SK-N-SH cells exhibit a much stronger attachment to vitronectin than the IMR-32 cells, which attach poorly to this substrate. Affinity chromatography of octylglucoside extracts of 125I surface-labeled cells on GRGDSPK-Sepharose columns resulted in the specific binding and elution with GRGDSP of three radiolabeled polypeptides with relative molecular masses of 135, 115, and 90 kD when analyzed by SDS-PAGE under nonreducing conditions. In the SK-N-SH cells the 135- and 90-kD polypeptides were more abundant whereas in the IMR-32 cells the 135- and 115-kD polypeptides were more highly expressed. Liposomes prepared from fractions containing all three polypeptides bound to vitronectin, fibronectin, and type I collagen, whereas liposomes prepared from the 135- and 115-kD polypeptides bound only to fibronectin and type I collagen. Polyclonal antibodies against the alpha/beta complexes of both the vitronectin receptor and the fibronectin receptor immunoprecipitated all three polypeptides. A monoclonal antibody against beta 1 immunoprecipitated only the 135- and the 115-kD polypeptides, whereas a monoclonal antibody against beta 3 subunit immunoprecipitated the 135- and 90-kD polypeptides. Although, the 115-kD polypeptide could be recognized by an anti-beta 1 antibody, a comparison of peptide maps generated by V8 protease digestion of the 115-kD polypeptide and beta 1 subunit immunoprecipitated from GRGDSPK-Sepharose flow-through material indicated that these two polypeptides are distinct. Depletion of the 90-kD polypeptide with an anti-beta 3 monoclonal antibody did not effect the ability of the 115- and 135-kD polypeptides to bind to GRGDSPK-Sepharose. These data indicate that the SK-N-SH and IMR-32 neuroblastoma cells express a novel "beta 1-like" integrin subunit that can associate with alpha v and can bind to RGD. We propose to name this beta 1-like subunit beta n. The data reported here thus demonstrate that in these two cell lines alpha v associates with two beta subunits, beta n and beta 3, forming two heterodimers. The alpha v beta n complex mediates binding to fibronectin and type I collagen, whereas the alpha v beta 3 complex mediates binding to vitronectin.
我们报告了从两个人神经母细胞瘤细胞系中分离出一种能与玻连蛋白、纤连蛋白和I型胶原结合的精氨酸-甘氨酸-天冬氨酸(Arg-Gly-Asp,RGD)依赖性整合素复合物。这两个人神经母细胞瘤细胞系,SK-N-SH和IMR-32,表现出对纤连蛋白和I型胶原的特异性附着。SK-N-SH细胞对玻连蛋白的附着比IMR-32细胞强得多,而IMR-32细胞对这种底物的附着较差。用GRGDSPK-琼脂糖柱对125I表面标记细胞的辛基葡糖苷提取物进行亲和层析,在非还原条件下通过SDS-PAGE分析,结果显示三种相对分子质量分别为135、115和90 kD的放射性标记多肽与GRGDSP发生特异性结合并被洗脱。在SK-N-SH细胞中,135-kD和90-kD多肽含量更高,而在IMR-32细胞中,135-kD和115-kD多肽表达水平更高。由包含所有三种多肽的组分制备的脂质体与玻连蛋白、纤连蛋白和I型胶原结合,而由135-kD和115-kD多肽制备的脂质体仅与纤连蛋白和I型胶原结合。针对玻连蛋白受体和纤连蛋白受体的α/β复合物的多克隆抗体免疫沉淀了所有三种多肽。一种针对β1的单克隆抗体仅免疫沉淀135-kD和115-kD多肽,而一种针对β3亚基的单克隆抗体免疫沉淀135-kD和90-kD多肽。尽管115-kD多肽可被抗β1抗体识别,但对115-kD多肽和从GRGDSPK-琼脂糖柱流出物中免疫沉淀的β1亚基经V8蛋白酶消化产生的肽图进行比较表明,这两种多肽是不同的。用抗β3单克隆抗体去除90-kD多肽并不影响115-kD和135-kD多肽与GRGDSPK-琼脂糖柱结合的能力。这些数据表明,SK-N-SH和IMR-32神经母细胞瘤细胞表达一种新型的“β1样”整合素亚基,它可以与αv结合并能与RGD结合。我们建议将这种β1样亚基命名为βn。因此,这里报告的数据表明,在这两个细胞系中,αv与两个β亚基βn和β3结合,形成两种异二聚体。αvβn复合物介导与纤连蛋白和I型胶原的结合,而αvβ3复合物介导与玻连蛋白的结合。